JP2017526674A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526674A5 JP2017526674A5 JP2017510870A JP2017510870A JP2017526674A5 JP 2017526674 A5 JP2017526674 A5 JP 2017526674A5 JP 2017510870 A JP2017510870 A JP 2017510870A JP 2017510870 A JP2017510870 A JP 2017510870A JP 2017526674 A5 JP2017526674 A5 JP 2017526674A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- acceptable salt
- group
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 17
- 125000003107 substituted aryl group Chemical group 0.000 claims 8
- 125000000547 substituted alkyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 5
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- -1 bromo, iodo Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 0 *c1c(*)nc(*=C)nc1* Chemical compound *c1c(*)nc(*=C)nc1* 0.000 description 2
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019218684A JP6968141B2 (ja) | 2014-08-25 | 2019-12-03 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
| JP2021174486A JP2022017384A (ja) | 2014-08-25 | 2021-10-26 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462041559P | 2014-08-25 | 2014-08-25 | |
| US62/041,559 | 2014-08-25 | ||
| US201562184212P | 2015-06-24 | 2015-06-24 | |
| US62/184,212 | 2015-06-24 | ||
| PCT/US2015/046777 WO2016033100A1 (en) | 2014-08-25 | 2015-08-25 | Novel ulk1 inhibitors and methods using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019218684A Division JP6968141B2 (ja) | 2014-08-25 | 2019-12-03 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526674A JP2017526674A (ja) | 2017-09-14 |
| JP2017526674A5 true JP2017526674A5 (2) | 2018-10-18 |
| JP6684780B2 JP6684780B2 (ja) | 2020-04-22 |
Family
ID=55400460
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510870A Active JP6684780B2 (ja) | 2014-08-25 | 2015-08-25 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
| JP2019218684A Active JP6968141B2 (ja) | 2014-08-25 | 2019-12-03 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
| JP2021174486A Pending JP2022017384A (ja) | 2014-08-25 | 2021-10-26 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019218684A Active JP6968141B2 (ja) | 2014-08-25 | 2019-12-03 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
| JP2021174486A Pending JP2022017384A (ja) | 2014-08-25 | 2021-10-26 | 新規ｕｌｋ１阻害剤およびそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10266549B2 (2) |
| EP (2) | EP3185868B1 (2) |
| JP (3) | JP6684780B2 (2) |
| CA (1) | CA2959347C (2) |
| DK (1) | DK3185868T3 (2) |
| ES (1) | ES2914099T3 (2) |
| WO (1) | WO2016033100A1 (2) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3185868T3 (da) * | 2014-08-25 | 2022-05-23 | Salk Inst For Biological Studi | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| US11028080B2 (en) * | 2016-03-11 | 2021-06-08 | Denali Therapeutics Inc. | Substituted pyrimidines as LRKK2 inhibitors |
| MD3472153T2 (ro) | 2016-06-16 | 2022-03-31 | Denali Therapeutics Inc | Pirimidin-2-ilamino-1H-pirazoli în calitate de inhibitori L RRK2 pentru utilizare în tratamentul tulburărilor neurodegenerative |
| EP3630291B9 (en) | 2017-05-26 | 2024-05-29 | Cancer Research Technology Limited | Benzimidazolone derived inhibitors of bcl6 |
| CN111278816B (zh) * | 2017-09-04 | 2024-03-15 | C4医药公司 | 二氢喹啉酮 |
| US10883992B2 (en) * | 2018-02-22 | 2021-01-05 | Regents Of The University Of Minnesota | Universal kinase substrates and methods of use thereof |
| ES3060268T3 (en) | 2018-04-13 | 2026-03-25 | Cancer Research Tech Ltd | Bcl6 inhibitors |
| CN111362922A (zh) * | 2018-12-26 | 2020-07-03 | 上海喆邺生物科技有限公司 | 2,4-二氨基嘧啶衍生物及其用途 |
| CN111362928A (zh) * | 2018-12-26 | 2020-07-03 | 上海喆邺生物科技有限公司 | 2,4-二氨基嘧啶衍生物 |
| EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
| MX2021013662A (es) | 2019-05-10 | 2022-03-11 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos. |
| IL325201A (en) * | 2019-06-17 | 2026-02-01 | Deciphera Pharmaceuticals Llc | Aminopyrimidine amide autophagy inhibitors and methods of using them |
| JP2022539208A (ja) | 2019-07-03 | 2022-09-07 | スミトモ ファーマ オンコロジー， インコーポレイテッド | チロシンキナーゼ非受容体１（ｔｎｋ１）阻害剤およびその使用 |
| GB201914860D0 (en) | 2019-10-14 | 2019-11-27 | Cancer Research Tech Ltd | Inhibitor compounds |
| AU2020385527B2 (en) * | 2019-11-21 | 2023-04-13 | Tyk Medicines, Inc. | Compound used as EGFR kinase inhibitor and use thereof |
| WO2021113689A1 (en) * | 2019-12-06 | 2021-06-10 | Yale University | Spak/osr inhibitors and methods of using same |
| WO2021155185A1 (en) * | 2020-01-30 | 2021-08-05 | Sumitomo Dainippon Pharma Oncology, Inc. | Aminopyrimidinylaminobenzonitrile derivatives as nek2 inhibitors |
| CN115023421B (zh) * | 2020-02-12 | 2024-05-24 | 优迈特株式会社 | 含氟嘧啶化合物及其制造方法 |
| CN115515589A (zh) * | 2020-02-14 | 2022-12-23 | 萨克生物研究学院 | Ulk1/2抑制剂及其使用方法 |
| KR20220153582A (ko) * | 2020-02-14 | 2022-11-18 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 마크로시클릭 ulk1/2 억제제 |
| JP2023513797A (ja) * | 2020-02-14 | 2023-04-03 | ソーク インスティテュート フォー バイオロジカル スタディーズ | Ｕｌｋ１／２阻害剤による単剤療法および併用療法 |
| TW202204339A (zh) | 2020-03-31 | 2022-02-01 | 美商施萬生物製藥研發 Ip有限責任公司 | 經取代的嘧啶及使用方法 |
| CN111484484B (zh) * | 2020-04-13 | 2021-11-23 | 沈阳药科大学 | 含芳杂环的2,4-二芳氨基嘧啶衍生物及其制备与应用 |
| CN111732548B (zh) * | 2020-06-11 | 2022-06-17 | 浙江大学 | N2-氨甲酰芳环-2-氨基嘧啶类衍生物及其医药用途 |
| JP7801084B2 (ja) * | 2020-09-22 | 2026-01-16 | ベイジーン リミテッド | Ｅｇｆｒ阻害剤としてのインドリン化合物及び誘導体 |
| WO2022063140A1 (en) * | 2020-09-23 | 2022-03-31 | Shenzhen Ionova Life Science Co., Ltd. | Pyrimidine and pyridine derivatives as hpk1 modulator and methods using same |
| WO2022072668A1 (en) * | 2020-09-30 | 2022-04-07 | Salk Institute For Biological Studies | Patient selection biomarkers for treatment with ulk inhibitors |
| CN112920124B (zh) * | 2021-01-29 | 2024-03-01 | 安徽医科大学 | 一种嘧啶-2,4-二胺类化合物及其制备方法与应用 |
| WO2023059786A1 (en) * | 2021-10-06 | 2023-04-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Inhibitors of ulk1 and methods of use |
| CN117736198A (zh) * | 2022-09-21 | 2024-03-22 | 科辉智药生物科技(深圳)有限公司 | 大环含氮冠醚化合物及其作为蛋白激酶抑制剂的应用 |
| WO2024073073A2 (en) * | 2022-09-30 | 2024-04-04 | Neuron23, Inc. | Kinase modulators and methods of use thereof |
| WO2024140401A1 (zh) * | 2022-12-30 | 2024-07-04 | 捷思英达控股有限公司 | 作为激酶抑制剂的杂环化合物以及包括其的组合物 |
| CN116768885B (zh) * | 2023-03-14 | 2026-03-24 | 浙江大学 | N2-取代双环-2-氨基嘧啶类衍生物、其制备方法及医药用途 |
| WO2024233766A1 (en) * | 2023-05-10 | 2024-11-14 | Erasca, Inc. | Macrocyclic ulk1/2 inhibitors and their use thereof |
| EP4719415A2 (en) * | 2023-05-30 | 2026-04-08 | The Trustees of The University of Pennsylvania | Radiolabeled compounds of trimethoprim and uses thereof |
| WO2025045182A1 (zh) * | 2023-09-01 | 2025-03-06 | 深圳众格生物科技有限公司 | Ulk1抑制剂及其制备方法和用途 |
| WO2025045203A1 (zh) * | 2023-09-01 | 2025-03-06 | 葆元生物医药科技(杭州)有限公司 | 杂环化合物及其中间体和应用 |
| WO2025117886A1 (en) * | 2023-12-01 | 2025-06-05 | Casma Therapeutics, Inc. | Ulk complex modulators and uses thereof |
| WO2025166124A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
| WO2025166180A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
| WO2025166161A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| CA1256638A (en) | 1984-07-06 | 1989-06-27 | Motoaki Tanaka | Polymer and its production |
| JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
| GB0206215D0 (en) * | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
| UA80767C2 (en) * | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| ES2325440T3 (es) * | 2003-02-20 | 2009-09-04 | Smithkline Beecham Corporation | Compuestos de pirimidina. |
| GB0305929D0 (en) * | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| US7504396B2 (en) * | 2003-06-24 | 2009-03-17 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| WO2005049021A1 (en) | 2003-11-03 | 2005-06-02 | Oy Helsinki Transplantation R & D Ltd | Materials and methods for inhibiting neointimal hyperplasia |
| WO2006124874A2 (en) * | 2005-05-12 | 2006-11-23 | Kalypsys, Inc. | Inhibitors of b-raf kinase |
| DE102007010801A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
| JP2011505407A (ja) * | 2007-12-03 | 2011-02-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 過剰な又は異常な細胞増殖を特徴とする疾患を治療するためのジアミノピリジン |
| WO2009083185A2 (en) | 2007-12-28 | 2009-07-09 | Fovea Pharmaceuticals Sa | Compositions and methods for prophylaxis and treatment of cellular degenerative ophthalmic disorders |
| EA024109B1 (ru) | 2008-04-16 | 2016-08-31 | Портола Фармасьютиклз, Инк. | Ингибиторы протеинкиназ |
| US8338439B2 (en) * | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| US20120114637A1 (en) | 2009-05-04 | 2012-05-10 | Santen Pharmaceutical Co., Ltd. | Mtor pathway inhibitors for treating ocular disorders |
| US20120165332A1 (en) * | 2009-06-18 | 2012-06-28 | Cellzome Limited | Sulfonamides and sulfamides as zap-70 inhibitors |
| US20130040310A1 (en) | 2009-12-15 | 2013-02-14 | Salk Institute For Biological Studies | Ulk1 compositions, inhibitors, screening and methods of use |
| WO2011084108A1 (en) | 2010-01-08 | 2011-07-14 | Agency For Science, Technology And Research | Methods and compositions for treating cancer |
| WO2011133668A2 (en) | 2010-04-20 | 2011-10-27 | President And Fellows Of Harvard College | Methods and compositions for the treatment of cancer |
| SG10201505217WA (en) | 2010-07-09 | 2015-08-28 | Biogen Hemophilia Inc | Chimeric clotting factors |
| DE102010034699A1 (de) * | 2010-08-18 | 2012-02-23 | Merck Patent Gmbh | Pyrimidinderivate |
| WO2012040602A2 (en) * | 2010-09-23 | 2012-03-29 | President And Fellows Of Harvard College | Targeting mtor substrates in treating proliferative diseases |
| WO2012045195A1 (en) * | 2010-10-09 | 2012-04-12 | Abbott Laboratories | Pyrrolopyrimidines as fak and alk inhibiters for treatment of cancers and other diseases |
| US8691777B2 (en) * | 2011-01-27 | 2014-04-08 | Emory University | Combination therapy |
| US20120244209A1 (en) | 2011-03-02 | 2012-09-27 | Roth Jack A | Tusc2 therapies |
| JP2014511391A (ja) * | 2011-03-07 | 2014-05-15 | フォンダッツィオーネ・テレソン | Ｔｆｅｂリン酸化阻害剤およびその使用 |
| EP2780017A1 (en) * | 2011-11-15 | 2014-09-24 | Novartis AG | Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the janus kinase 2-signal transducer and activator of transcription 5 pathway |
| US20130310340A1 (en) * | 2012-05-16 | 2013-11-21 | Rigel Pharmaceuticals, Inc. | Method of treating muscular degradation |
| US20150250808A1 (en) * | 2012-10-15 | 2015-09-10 | Vojo P. Deretic | Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits |
| EP2914296B2 (en) | 2012-11-01 | 2021-09-29 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
| WO2014098932A1 (en) | 2012-12-17 | 2014-06-26 | The Brigham And Women's Hosptial, Inc. | Treatment of mtor hyperactive related diseases and disorders |
| CN103059030B (zh) * | 2012-12-28 | 2015-04-29 | 北京师范大学 | 一种具有粘着斑激酶抑制作用的嘧啶类化合物及其制备方法和应用 |
| CA2899281C (en) | 2013-01-25 | 2022-05-31 | Rigel Pharmaceuticals, Inc. | Pyrimidinediamine compounds for use in treating or preventing autoimmune alopecia |
| DK3185868T3 (da) | 2014-08-25 | 2022-05-23 | Salk Inst For Biological Studi | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme |
-
2015
- 2015-08-25 DK DK15836833.2T patent/DK3185868T3/da active
- 2015-08-25 JP JP2017510870A patent/JP6684780B2/ja active Active
- 2015-08-25 CA CA2959347A patent/CA2959347C/en active Active
- 2015-08-25 WO PCT/US2015/046777 patent/WO2016033100A1/en not_active Ceased
- 2015-08-25 ES ES15836833T patent/ES2914099T3/es active Active
- 2015-08-25 EP EP15836833.2A patent/EP3185868B1/en active Active
- 2015-08-25 EP EP22159448.4A patent/EP4070795A1/en active Pending
- 2015-08-25 US US15/505,532 patent/US10266549B2/en active Active
-
2019
- 2019-02-06 US US16/269,468 patent/US10689397B2/en active Active
- 2019-04-19 US US16/389,784 patent/US10774092B2/en active Active
- 2019-04-19 US US16/389,793 patent/US20190284207A1/en not_active Abandoned
- 2019-12-03 JP JP2019218684A patent/JP6968141B2/ja active Active
-
2021
- 2021-10-26 JP JP2021174486A patent/JP2022017384A/ja active Pending